NCT05331222 is a NA clinical trial of JT-1 in Chronic Rhinitis, sponsored by Jantar GmbH.

Who is sponsoring NCT05331222?

NCT05331222 is sponsored by Jantar GmbH.

What drugs are being tested in NCT05331222?

Interventions in NCT05331222: JT-1.

What condition does NCT05331222 study?

NCT05331222 studies Chronic Rhinitis, Chronic Sinus Congestion.

Is NCT05331222 still recruiting?

NCT05331222 is currently terminated. Last updated 21 March 2023.

Last reviewed 2023-03-21 · How we verify

NCT05331222

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis

Terminated NA Last updated 21 March 2023

What this trial tests

NA trial testing JT-1 in Chronic Rhinitis in 3 participants. Terminated before completion.

Timeline

30 September 2022

Primary endpoint
3 March 2023

3 March 2023

Quick facts

Lead sponsor	Jantar GmbH
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	3
Start date	30 September 2022
Primary completion	3 March 2023
Estimated completion	3 March 2023
Sites	1 location across Switzerland

Drugs / interventions tested

JT-1 — full drug profile →

Conditions studied

Chronic Rhinitis — all drugs for Chronic Rhinitis →
Chronic Sinus Congestion — all drugs for Chronic Sinus Congestion →

Sponsor

Jantar GmbH — full company profile →

Who can join

18 and older, any sex, with Chronic Rhinitis or Chronic Sinus Congestion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proof-of-concept study with a novel nasal spray in chronic rhinitis or chronic sinusitis. The study will involve 25 patients completing the study for a per protocol analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Rhinitis

Currently open trials in the same condition.

NCT06999044 — Study on the Optimization of the Diagnostic Process for Chronic Rhinitis Using Nasal Allergen Provocation Test · recruiting
NCT06370468 — The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05331222 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jantar GmbH
Last refreshed: 21 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05331222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing